Arovella Therapeutics Limited has released a press release.
Clinical manufacturing batch released, first site activated
Earlier from Arovella Therapeutics
- Arovella Appoints Acting CEO
- Board Refresh and CEO Resignation
- CLDN18.2 CAR iNKT Cell Preclinical Data Update
- Half Year Report and Appendix 4D